St Jude Children’s Research Hospital is Recipient of Employee-Selected Charitable Donation
We’re thrilled to announce that YMC America has made a significant donation to St. Jude Children’s Research Hospital!
We believe in giving back to our community and supporting causes that make a real difference. In 2024, we empowered our employees to choose the organization we would support. We held a company-wide vote, and the final choice was St. Jude Children’s Research Hospital.
St. Jude is an extraordinary institution dedicated to advancing cures and means of prevention for pediatric catastrophic diseases through research and treatment.
We’re proud to contribute to their life-saving work and to support their mission of ensuring that no child is denied treatment based on race, religion or a family’s ability to pay. We welcomed Dixon Williams from the regional St Jude office to our facility for a check presentation.
We’re truly fortunate to have such a caring and generous team at YMC and look forward to continuing this project throughout 2025 as well.
Cake was shared as part of the celebration!
Previous Article
Lunch from Around the World Related Posts
June 18, 2026
Happy Retirement, John!
Today, we are celebrating John Heffernan, who is officially stepping into retirement after 16 years with YMC America.
John’s journey with us actually began back when we were known as Integrated Process Technologies, long before we transitioned to YMC America. Over the years, John has worn many hats, from Project Manager to Estimating Manager, Engineering Manager, and ultimately Director of Business Development.
June 2, 2026
Chromatography of Biotherapeuticals – Analyzing and Purifying Peptides and Oligonucleotides
This webinar will highlight how advanced ultra-high-performance liquid chromatography (UHPLC) strategies, carefully selected stationary phases, and bioinert hardware can significantly improve the analysis and purification of peptides and oligonucleotides.
May 21, 2026
Breaking Down mRNA Capping Efficiency with High-Resolution IP-RP LC
Evaluating 5' capping efficiency is a critical quality attribute in therapeutic mRNA manufacturing, directly impacting translation efficiency and transcript stability. However, separating structurally similar capped, partially capped, and uncapped species differing by just a single nucleotide remains a significant chromatographic challenge.
